“Severely flawed” is a cardiologist’s verdict on a peer-reviewed study funded by the Food and Drug Administration (FDA) suggesting possible risks of developing myocarditis and pericarditis after getting a COVID-19 vaccine.
The recent FDA study published on June 11, 2022, used health insurance databases to identify myocarditis or pericarditis hospitalizations occurring in people aged 18 to 64 years, 1 to 7 days after a Pfizer or Moderna vaccine.
